Jan 3, 2017 ... Amgen Inc. et al v. Sanofi et al, No. 1:2014cv01317 - Document 389 (D. Del. 2017) case opinion from the District of Delaware US Federal District Court.
Med Law Rev. 2018 Feb 1;26(1):134-145. doi: 10.1093/medlaw/fwx049. C-621/ 15 - W and Others v Sanofi Pasteur: An Example of Judicial Distortion and Indifference to Science. Smillie LR(1), Eccleston-Turner MR(2), Cooper SL(1). Author information: (1)School of Law, Birmingham City University, Birmingham, UK.
Eli Lilly and Co. and Pfizer Inc. have thrown their support behind Sanofi SA and its partner Regeneron Pharmaceuticals in a Federal Circuit case over patents for a cholesterol-lowering drug, saying in amicus briefs that the appeals court should undo district court decisions that upheld competitor Amgen Inc.’s ...
Jul 2, 2017 ... This is likely to be the case with the European Court of Justice (ECJ) decision on vaccine manufacturers' liability, N.W. et al. v. Sanofi Pasteur MSD, C‑621/15. Popular press reacted to this decision with sharp criticism that included unsubstantiated assertions about the European law of products liability, ...
Parties, docket activity and news coverage of federal case Amgen Inc. et al v. Sanofi et al, case number 1:14-cv-01317, from Delaware Court.